IMMUTEP LIMITED - AMER
2.0306
08-十月-24 11:43:48
15 分钟延时
股票
-0.0194
-0.95%
今日范围
2.0200 - 2.0500
ISIN
N/A
来源
NASDAQ
-
29 10月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report & Appendix 4C
28 10月 2021 08:00:02 条件 Nasdaq GlobeNewswire
-
Immutep to Present Phase II TACTI-002 Data at SITC 2021
01 10月 2021 08:00:02 条件 Nasdaq GlobeNewswire
-
Immutep Receives A$3.4 million R&D Tax Incentive from French Government
29 9月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep to Present at Healthcare Investor Conferences
28 9月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
21 9月 2021 08:38:03 条件 Nasdaq GlobeNewswire
-
Immutep Completes Recruitment of 2nd line PD-1/PD-L1 refractory NSCLC Patients in TACTI-002
01 9月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep’s Chinese Partner, Eoc Pharma, Expands Efti Trial Pipeline
31 8月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525
27 8月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
05 8月 2021 08:00:02 条件 Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report
13 7月 2021 08:00:03 条件 Nasdaq GlobeNewswire
-
Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC
06 7月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
21 6月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
21 6月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Immutep Reveals a New Anti-LAG-3 Research Program
08 6月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Reports Positive Data from its TACTI-002 Phase II Study of LAG-3 Therapy, Efti, at ASCO 2021
04 6月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
04 6月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
02 6月 2021 08:00:02 条件 Nasdaq GlobeNewswire
-
Immutep Enters Into A New Collaboration With Merck KGaA, Darmstadt, Germany For LAG-3 Therapy, Efti
01 6月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Immutep Granted Chinese Patent For Eftilagimod Alpha In Chemo-Immunotherapy Combination
26 5月 2021 08:00:01 条件 Nasdaq GlobeNewswire